IntermediateGrowth StrategyHealthcare & Life SciencesBCG

Pharmaceutical Rare Disease Business Growth

Published March 7, 2025

Industry: Pharmaceuticals Case Type: Growth Strategy Difficulty: Medium Firm (if applicable): BCG

About this Case

Type:Growth Strategy
Difficulty:Intermediate
Industries:Healthcare & Life Sciences
Source:BCG
Published:March 7, 2025